Hamilton Lane

HLNE · NASDAQ

$83.70+$1.44 (+1.75%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $82.26

HLNE analyst rating

BuyConsensus of 9 analysts over the last 12 months. 89% rate it a buy.

Strong buy0
Buy8
Hold1
Underperform0
Sell0

12-month price target · 9 analysts

Average $135.49 (+61.9% upside)

Low: $117.16
Now: $83.70
High: $190.05

Upgrades and downgrades

The latest rating actions, newest first

HLNE analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
UBS	Oct 13, 2026	Maintains	Buy	$131.00 → $115.00	43%
Wells Fargo	Oct 2, 2026	Initiates	Overweight	$103.00	63%
Oppenheimer	Aug 27, 2026	Maintains	Outperform	$182.00 → $181.00	67%
UBS	Aug 5, 2026	Maintains	Buy	$114.00 → $131.00	43%
Oppenheimer	Aug 5, 2026	Maintains	Outperform	$174.00 → $182.00	67%
Keefe, Bruyette & Woods	Aug 5, 2026	Maintains	Outperform	$105.00 → $116.00	59%
Morgan Stanley	Jul 21, 2026	Maintains	Equal-Weight	$141.00 → $123.00	54%
Oppenheimer	Jul 17, 2026	Maintains	Outperform	$176.00 → $174.00	67%
Keefe, Bruyette & Woods	Jul 10, 2026	Maintains	Outperform	$115.00 → $105.00	59%
Goldman Sachs	Jun 30, 2026	Maintains	Buy	$148.00 → $128.00	61%

The case for and against

Updated Jan 26, 2026

Bull case

Hamilton Lane Inc has demonstrated significant growth with its evergreen platform's FPAUM reaching $12.5 billion, reflecting an impressive year-over-year increase of approximately 65%, while also reporting strong inflow trends. Furthermore, the firm's estimates for future revenue performance have seen substantial revisions, with projected FRPR increasing to $83 million and $98 million for fiscal years 2026 and 2027, respectively, alongside higher anticipated performance fees of $156 million and $191 million for the same periods. This combination of robust asset growth and favorable performance fee projections underscores a positive outlook for Hamilton Lane's financial performance moving forward.

Bear case

Hamilton Lane Inc. reported a slight decline in capital raised, with $3.4 billion in the latest quarter, down from $3.5 billion the previous quarter, despite aligning with consensus estimates. This stagnation in capital raising may signal a potential slowdown in demand or investor confidence in private markets. Furthermore, the firm faces challenges due to limited transparency surrounding its investment products and strategies, which could deter potential investors and impact future growth.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.